Showing results (51-60 of 203) with videos related to
Sort By:
Pageof 21
Critical Reviews in Oncology/Hematology|August 2, 2008
Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational studyChristophe Locher, Elizabeth Fabre-Guillevin, Francesco Brunetti, et al.Therapeutic Innovation & Regulatory Science|October 21, 2022
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator OutcomesSylviane de Viron, Laura Trotta, William Steijn, et al.Pharmaceutical Statistics|November 2, 2022
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomesMickaël De Backer, Catherine Legrand, Julien Péron, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2019
Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLCJacek Rutkowski, Everardo D Saad, Tomasz Burzykowski, et al.Therapeutic Innovation & Regulatory Science|February 9, 2024
Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical TrialsSylviane de Viron, Laura Trotta, William Steijn, et al.Nuclear Medicine Communications|November 3, 2005
FDG PET in patients with cancer of an unknown primaryHélène Kolesnikov-Gauthier, Eric Levy, Pascal Merlet, et al.Future Oncology (London, England)|September 13, 2019
Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III studyTimothy S Pardee, Sanjeev Luther, Marc Buyse, et al.Controlled Clinical Trials|December 31, 2002
Statistical challenges in the evaluation of surrogate endpoints in randomized trialsGeert Molenberghs, Marc Buyse, Helena Geys, et al.Nature Reviews. Clinical Oncology|April 7, 2010
Biomarkers and surrogate end points--the challenge of statistical validationMarc Buyse, Daniel J Sargent, Axel Grothey, et al.Biometrics|October 3, 2014
On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsAriel Alonso, Wim Van der Elst, Geert Molenberghs, et al.Pageof 21